| Effect of recombinant human pentraxin 2 vs placebo on change in forced vital capacity in patients with idiopathic pulmonary fibrosis: a randomized clinical trial G Raghu, B Van Den Blink, MJ Hamblin, AW Brown, JA Golden, LA Ho, ... Jama 319 (22), 2299-2307, 2018 | 222 | 2018 |
| Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation S Agbor-Enoh, Y Wang, I Tunc, MK Jang, A Davis, I De Vlaminck, ... EBioMedicine 40, 541-553, 2019 | 138 | 2019 |
| Outcomes after hospitalization in idiopathic pulmonary fibrosis: a cohort study AW Brown, CP Fischer, OA Shlobin, RG Buhr, S Ahmad, NA Weir, ... Chest 147 (1), 173-179, 2015 | 90 | 2015 |
| Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease S Shin, CS King, AW Brown, MC Albano, M Atkins, MJ Sheridan, S Ahmad, ... Respiratory medicine 108 (11), 1626-1632, 2014 | 90 | 2014 |
| Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study G Raghu, B van den Blink, MJ Hamblin, AW Brown, JA Golden, LA Ho, ... The Lancet Respiratory Medicine 7 (8), 657-664, 2019 | 81 | 2019 |
| Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: evidence from cell-free DNA analysis S Agbor-Enoh, AM Jackson, I Tunc, GJ Berry, A Cochrane, D Grimm, ... The Journal of Heart and Lung Transplantation 37 (7), 925-932, 2018 | 77 | 2018 |
| The value and application of the 6-minute-walk test in idiopathic pulmonary fibrosis AW Brown, SD Nathan Annals of the American Thoracic Society 15 (1), 3-10, 2018 | 72 | 2018 |
| The red cell distribution width as a prognostic indicator in idiopathic pulmonary fibrosis SD Nathan, T Reffett, AW Brown, CP Fischer, OA Shlobin, S Ahmad, ... Chest 143 (6), 1692-1698, 2013 | 66 | 2013 |
| The influence of alternative instruction on 6-min walk test distance NA Weir, AW Brown, OA Shlobin, MA Smith, T Reffett, E Battle, S Ahmad, ... Chest 144 (6), 1900-1905, 2013 | 62 | 2013 |
| Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis S Shin, CS King, N Puri, OA Shlobin, AW Brown, S Ahmad, NA Weir, ... European Respiratory Journal 47 (5), 1445-1451, 2016 | 52 | 2016 |
| Lung transplantation in IIP: A review AW Brown, H Kaya, SD Nathan Respirology 21 (7), 1173-1184, 2016 | 49 | 2016 |
| Single‐center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients S Aryal, SB Katugaha, A Cochrane, AW Brown, SD Nathan, OA Shlobin, ... Transplant Infectious Disease, e13166, 2019 | 46 | 2019 |
| Dynamic patient counseling: a novel concept in idiopathic pulmonary fibrosis AW Brown, OA Shlobin, N Weir, MC Albano, S Ahmad, M Smith, K Leslie, ... Chest 142 (4), 1005-1010, 2012 | 44 | 2012 |
| Critical care of the adult patient with cystic fibrosis CS King, AW Brown, S Aryal, K Ahmad, S Donaldson Chest 155 (1), 202-214, 2019 | 35 | 2019 |
| Hypertonic saline has a prolonged effect on mucociliary clearance in adults with cystic fibrosis AT Trimble, AW Brown, BL Laube, N Lechtzin, KL Zeman, J Wu, A Ceppe, ... Journal of Cystic Fibrosis 17 (5), 650-656, 2018 | 33 | 2018 |
| Pulmonary hypertension in diffuse parenchymal lung diseases OA Shlobin, AW Brown, SD Nathan Chest 151 (1), 204-214, 2017 | 25 | 2017 |
| Hemothorax following lung transplantation: incidence, risk factors, and effect on morbidity and mortality A Hong, CS King, AWW Brown, S Ahmad, OA Shlobin, S Khandhar, ... Multidisciplinary respiratory medicine 11 (1), 40, 2016 | 25 | 2016 |
| Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia CS King, AW Brown, OA Shlobin, N Weir, M Libre, D Franco-Palacios, ... European Respiratory Journal 52 (1), 1800545, 2018 | 21 | 2018 |
| Multimodal noninvasive prediction of pulmonary hypertension in IPF R Sonti, RA Gersten, S Barnett, AW Brown, SD Nathan The clinical respiratory journal 13 (9), 567-573, 2019 | 17 | 2019 |
| Connective tissue disease-associated interstitial lung disease and outcomes after hospitalization: A cohort study AP Ratwani, KI Ahmad, SD Barnett, SD Nathan, AW Brown Respiratory medicine 154, 1-5, 2019 | 15 | 2019 |
